Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Controlled, Double-Blind, Phase II Study To Assess Safety and Efficacy With the Renal Assist Device (RAD) in Patients With Acute Renal Failure

NCT00280072 is registered in ClinicalTrials.gov with RenaMed Biologics as lead sponsor.

NCT NCT00280072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Controlled, Double-Blind, Phase II Study To Assess Safety and Efficacy With the Renal Assist Device (RAD) in Patients With Acute Renal Failure
Lead sponsor
RenaMed Biologics
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2006
Completion date
August 31, 2007
Enrollment
Not reported
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, acute